The phase 3 STRIDE-10 trial evaluated the safety and immunogenicity of V116 in pneumococcal vaccine-naive adults 50 years of age and older.

More than half are very likely to get vaccinated; vaccination rates higher for those who perceive RSV as serious

Findings based on review of national versus WHO guidelines

HealthDay News — Measles infections continue to spread across the country, with 125 cases now reported in 18 states, new US government data shows. That is more cases than were reported in all of 2022, the most recent annual peak for measles infections, the US Centers of Disease Control and Prevention reported Friday. So far this…

Children aged 24 to 59 months were 4.86 times as likely to be hospitalized in 2022 vs 2015 to 2019.

A regulatory decision is expected on February 14, 2025.

Patients with accelerated HBV vaccination who experience seroconversion might be eligible to receive a kidney transplant from a hepatitis B-positive donor.

Risk for experiencing acute cardiac event higher for adults with underlying cardiovascular disease

The increase in cases in 2024 suggests that additional efforts are needed to encourage MMR vaccination.

SuVax is a subunit protein vaccine of recombinantly expressed Sudan ebolavirus glycoprotein.